AEONF news

Latest 1 stories · newest Nov 3, 2026

AEONF

Aeon lowers warrant exercise price to $0.20

Aeon Biopharma amended its two-year milestone warrants to lower the exercise price for common stock to $0.20, supported by holders representing at least 67% of the potential shares. This corporate action was filed with the SEC on November 2, 2026.

Offering Nov 3, 2026 sentiment -0.30 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same AEONF feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/AEONF/newsSTART FREE